Quillivant XR 25 MG/5 ML susp 180ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCU0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,088
Award facts
- Contract value 100% obligated
- $1,088.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,088.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL). This non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with the parent IDC enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 11, 2025. Quillivant XR is an extended-release methylphenidate formulation used in the treatment of attention-deficit/hyperactivity disorder. This award reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through competitively awarded contracts that demonstrate the company's capability to fulfill specialized pharmaceutical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FCU0N?
SPE2DR26FCU0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FCU0N worth?
The government has obligated $1,088 on SPE2DR26FCU0N.
Is contract SPE2DR26FCU0N an order under another contract?
Yes. SPE2DR26FCU0N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCU0N competed?
The extent of competition for SPE2DR26FCU0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award